Skip to main content
ICRweb
About Issuing Certificates

ICR Contents

Regulatory Guidelines
All Contents
  • Fresh Insights Playlist
    • Collaboration in cancer research across different Asian countries| ATLAS Webinar Apr 2025
    • Academia-Regulatory Collaboration for Asian Therapeutic Development| ATLAS Webinar May 2025
    • Locally Advanced Rectal Cancer| ATLAS Webinar July 2025
    • Endoscopy| ATLAS Webinar Jan 2025
    • Cervical Cancer| ATLAS Webinar Feb 2025
    • Sarcoma| ATLAS Webinar Mar 2025
    • Randomization and Confounding
    • Multivariate Analysis 1
  • Recommended Lectures
    • Cancer Biology and Molecular Biology
    • Sample handling
    • Procedures and Interpretation of Next Generation Sequencing Results
    • Methods of utilizing NGS test results (off-label, clinical trial, etc.)
    • ISO 15189 accreditation program for molecular-genetic laboratories
    • Basic Knowledge and Practical Consideration of Phase I Trials in Oncology
    • The General Role Of CRCs In Cancer Clinical Trials
    • Review of cancer clinical trial protocols from a CRC perspective
    • Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2
    • Designs for clinical trials on cancer - Part 1 of 2
What is ICRweb? What is ATLAS? FAQ Contact

Visitor Counter

ICRweb
  • About ICRweb
  • What is ATLAS?
  • FAQ
  • Contact
  • Japanese
  • Log in
    Sign up

ICRweb: Introduction to Clinical Research (Guest)

Request for Updating your profile
due to site renewal

Thank you for using Introduction to Clinical Research (ICRweb) e-learning site. Please update your profile in order to improve our service to provide better lectures and information that you need.
Time required: Approximately 1 to 2 min.
Update your profile Later....
  • Cancer Genomic Medicine: Essential Course

    ATLAS (Asian clinical TriaLs network for cAncerS) project - Training Program
    Cancer Genomic Medicine Course
    Target trainees: Physicians, laboratory technicians and other relevant professionals who engage or would like to engage cancer genome-based medicine.

    • ATLAS PROJECT
    • The Mission of ATLAS [National Cancer Center Japan Hospital] - YouTube
    • ATLAS project | Facebook
    • ICRweb app is now available in English all over the world!
ICRweb app is now available in English all over the world!
ICRweb app is now available in English all over the world!

For more information about the app, please see here.

The ICRweb User Manual has been prepared.
The ICRweb User Manual has been prepared.
Please download it from the link below if you have any problems while exploring the ICRweb.
DOWNLOAD Link
Skip Latest announcements
Latest announcements
  • 09 Sep 2025
    3 videos added in the “ATLAS Monthly Webinar 2025” course
    NEW
  • 26 Aug 2025
    A new course “ATLAS Monthly Webinar 2025” launched with 3 contents
  • 29 Jul 2025
    New Lectures Added in “Biostatistics for Clinical Trials on Cancer” Course
  • 15 Jul 2025
    A new course, “Biostatistics for Clinical Trials on Cancer,” has launched with 4 lectures.
  • 07 Feb 2025
    Four new contents added to “ATLAS Monthly Webinar”
Older topics ...
Skip Fresh Insights Playlist
Fresh Insights Playlist
  • Embark on a learning adventure with our "Fresh Insights Playlist," a curated collection of the latest lectures that promise to spark curiosity and elevate your educational journey. Stay tuned for a dynamic blend of cutting-edge content designed to keep you at the forefront of knowledge.

    • 1:15:05

      Collaboration in cancer research across different Asian countries| ATLAS Webinar Apr 2025

      [Topic] Collaboration in cancer research across different Asian countries[Date] 24 Apr 2025 [Opening Remarks] 00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 06:05~APGOT experience of multi-national trials Speaker: Dr. David SP Tan (Department of Haematology-Oncology, National University Cancer Institute Singapore)[Lecture 2] 35:42~Experience with the Pathway TrialSpeaker: Dr. Kan Yonemori(Department of Medical Oncology, National Cancer Center Hospital Japan)[Discussion] 1:01:33~DiscussionFacilitator: Dr. Yap Yoon-Sim(Department of Medical Oncology National Cancer Centre Singapore)

      Views5

      User evaluation

      Updated on:24 Apr 2025 
    • 1:02:50

      Academia-Regulatory Collaboration for Asian Therapeutic Development| ATLAS Webinar May 2025

      [Topic] Academia-Regulatory Collaboration for Asian Therapeutic Development[Date] 29 May 2025 [Opening Remarks] 00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 03:12~Introduction to the PMDA Asia OfficeSpeaker: Dr. Jun Kitahara(Head, PMDA Asia Office, Japan)[Lecture 2] 21:41~Overview of the ATLAS ProjectSpeaker: Dr. Mitsumi Terada(Head, Asian Partnerships Section, National Cancer Center Hospital, Japan)[Discussion] 46:14~DiscussionFacilitator: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)

      Views3

      User evaluation

      Updated on:29 May 2025 
    • 1:15:44

      Locally Advanced Rectal Cancer| ATLAS Webinar July 2025

      [Topic] Locally Advanced Rectal Cancer[Date] 29 July 2025 [Opening Remarks] 00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 05:50~The Current Role of Radiotherapy in Locally Advanced Rectal CancerSpeaker: Dr. Keeratikarn Boonyawan(Bumrungrad International Hospital, Thailand)[Lecture 2] 35:41~Current Surgical Strategies for Rectal Cancer in JapanSpeaker: Dr. Yasuyuki Takamizawa(National Cancer Center, Japan)[Discussion] 59:09~DiscussionFacilitator: Dr. Ekaphop Sirachainan(Ramathibodi Hospital, Thailand)

      Views3

      User evaluation

      Updated on:29 July 2025 
    • 0:29:40

      Endoscopy| ATLAS Webinar Jan 2025

      [Topic] Endoscopy[Date] 27 Jan 2025 [Opening Remarks] 00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 04:54~Colonoscopy Quality Management in Colorectal Cancer Screening: A Successful Experience in Taiwan Speaker: Dr. Wenfeng Hsu (Department of Internal Medicine, National Taiwan University Hospital)Please note:Due to the presenter’s request, certain parts of the lecture have been omitted from this video. We appreciate your understanding.

      Views10

      User evaluation

      Updated on:27 Jan 2025 
    • 1:28:45

      Cervical Cancer| ATLAS Webinar Feb 2025

      [Topic] Cervical Cancer[Date] 24 Feb 2025 [Opening Remarks] 00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 06:40~Experience Sharing of Developing Cervical Cancer Care at Sarawak General Hospital, Malaysia Speaker: Dr Izzati Wan Maharuddin (Sarawak General Hospital)[Lecture 2] 38:59~Key updates of Management of Advanced Cervical Cancer CareSpeaker: Dr. Suwanit Therasakvichya(Department of Obstetrics and Gynecology Faculty of Medicine, Siriraj Hospital Mahidol University)[Discussion] 1:10:26~DiscussionFacilitator: Dr. Voon Pei Jay(Sarawak Generel Hospital)

      Views9

      User evaluation

      Updated on:24 Feb 2025 
    • 1:30:59

      Sarcoma| ATLAS Webinar Mar 2025

      [Topic] Sarcoma[Date]: 27 Mar 2025 [Opening Remarks] 00:00~Opening Remarks and Introduction of ATLASSpeaker: Dr. Yuta Sekino(General Manager, Asian Partnerships Office, National Cancer Center Hospital, Japan)[Lecture 1] 06:45~The diagnoses of sarcomas that are worth a million Speaker: Dr. Jen-Chieh Lee (National Taiwan University Hospital)[Lecture 2] 33:20~Combating Soft Tissue Sarcomas: Strategies for ImpactSpeaker: Dr. Valerie Shiwen Yang(National Cancer Centre Singapore)[Discussion] 56:27~DiscussionFacilitator: Dr. Tom Wei Wu Chen(National Taiwan University Hospital, Chair of ATLAS Sarcoma and Rare Cancer Group)

      Views7

      User evaluation

      Updated on:27 Mar 2025 
    • 1:06:14

      Randomization and Confounding

      In the previous lectures, we focused on explaining methods of data analysis according to the type of outcome.However, being able to analyze data does not necessarily mean that you will be able to correctly interpret the results.The purpose of this lecture is to understand "confounding," one of the most important concepts to understand in clinical research, and why randomized clinical trials are necessary.

      Views37

      User evaluation

      Updated on:29 May 2025
    • 0:45:36

      Multivariate Analysis 1

      This lecture will explain multivariate analysis, which is used to rule out confounding.A brief explanation of the structure of statistical models and how hazard ratios and odds ratios are estimated from statistical models will also be provided.

      Views13

      User evaluation

      Updated on:29 May 2025
    ‹
    ›
Skip Recommended Lectures
Recommended Lectures
  • The recommended lectures from each course have been picked out. This recommendations help you discover more of the lectures you are interested in.

    • 0:27:38

      Cancer Biology and Molecular Biology

      This content is going to discuss a lecture titled “Cancer Biology and Molecular Biology” for the Cancer Genome-based Medicine Course as part of the presentation series in the ATLAS Training Program.

      Views214

      User evaluation4.48

      Updated on:30 Nov 2021
    • 0:20:50

      Sample handling

      1. Sample Handling Process in Cancer Genomic Medicine2. Tumor Sample Evaluation Procedure3. Examples of Tumor Evaluation4. Tumor Sample Evaluation (Tumor Cell Content)

      Views91

      User evaluation4.35

      Updated on:29 Jun 2021
    • 0:18:06

      Procedures and Interpretation of Next Generation Sequencing Results

      1. Characteristics of gene panel tests and interpretation of the results2. Pathogenic significance of detected mutations3. Mutations and associated therapeutic agents4. Candidate drugs and their evidence levels

      Views68

      User evaluation4.22

      Updated on:9 Jul 2021
    • 0:18:25

      Methods of utilizing NGS test results (off-label, clinical trial, etc.)

      Information on the topics listed on this slide will be presented in the lecture.・Cancer genomic medicine and comprehensive genomic profiling (CGP) test・Treatment based on cancer genomic profiling

      Views72

      User evaluation4.33

      Updated on:12 Dec 2022
    • 0:34:37

      ISO 15189 accreditation program for molecular-genetic laboratories

      1. Efforts for quality assurance in molecular-genetic testing2. Implementation guidance of ISO 15189 for NGS-based tests3. Regional and international efforts to standardize the pre-examination process4. International efforts to standardize multiplex molecular-genetic tests5. Challenges to the EQA/PT program

      Views23

      User evaluation0.00

      Updated on:2 Jun 2021
    • 0:26:04

      Basic Knowledge and Practical Consideration of Phase I Trials in Oncology

      Information on the topics listed on this slide will be presented in the lecture.1. First administration of novel anticancer drugs in human.2. Determining the optimal dose and administration method.3. Dose escalation test using toxicity as an index.

      Views54

      User evaluation4.50

      Updated on:27 Mar 2023
    • 0:40:03

      The General Role Of CRCs In Cancer Clinical Trials

      1. Role of CRC in Cancer Clinical Trials2. Provide Support to Subjects Participating in Cancer Clinical Trials3. Support for conducting Cancer Clinical Trials

      Views47

      User evaluation4.39

      Updated on:23 May 2022
    • 0:28:53

      Review of cancer clinical trial protocols from a CRC perspective

      1. Role and definition of the protocol2. Perspective of CRC reading of the protocol3. Uncomfortable situations when conducting clinical trials4. Summary

      Views38

      User evaluation4.29

      Updated on:24 May 2022
    • 0:18:37

      Minimum statistical knowledge required for clinical trials on cancer - Part 1 of 2

      Some key points for interpreting the results of phase III randomized controlled trials are introduced in this lecture. Particularly, this part outlines survival curve and randomization.

      Views44

      User evaluation4.67

      Updated on:20 Sep 2023
    • 0:31:42

      Designs for clinical trials on cancer - Part 1 of 2

      Development flow and clinical trial designs of anticancer drugs are introduced in this lecture. Particularly, this part outlines development flow and phase I clinical trial designs.

      Views22

      User evaluation4.33

      Updated on:20 Sep 2023
    ‹
    ›

Introduction to Clinical Research

  • Top Page
  • What is ICRweb
  • Regulatory Guidelines
  • FAQ
  • Contact Us

Course List

Course List
  • Cancer Genomic Medicine: Essential Course
  • Cancer Genomic Medicine: the Practice in Japan
  • ISO 15189 Accreditation Support Course
  • Phase 1 Trial Development Course
  • CRC Training Course
  • Outline of Clinical Trials on Cancer
  • ATLAS International Symposium
  • SICRES seminar
  • Biostatistics for Clinical Trials on Cancer
  • ATLAS Monthly Webinar 2024
  • ATLAS Monthly Webinar 2025
  • Site Policy

Copyright © 2007-2024 ICRweb all rights reserved.